SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
12-Mar-24 1:47 PM View: | Aquestive Therapeutics, Inc. (AQST) | 09-Mar-24 | Payment of Exercise | 8,370 | $4.88 | $40,845.60 | (3%) 246.0K to 237.63K | |
11-Mar-24 10:35 AM View: | Aquestive Therapeutics, Inc. (AQST) | 07-Mar-24 | Grant | 86,250 | -- | -- | 54% 159.75K to 246.0K | |
09-Mar-23 3:07 PM View: | Aquestive Therapeutics, Inc. (AQST) | 09-Mar-23 | Grant | 100,000 | -- | -- | 168% 59.53K to 159.53K | |
15-Jun-22 10:24 AM View: | Aquestive Therapeutics, Inc. (AQST) | 14-Jun-22 | Private Purchase | 5,000 | $0.81 | $4,050.00 | 9% 54.53K to 59.53K | |
10-Jun-22 5:26 PM View: | Aquestive Therapeutics, Inc. (AQST) | 08-Jun-22 | Private Purchase | 2,293 | $0.96 | $2,201.28 | 4% 52.24K to 54.53K | |
18-Mar-20 4:45 PM View: | Aquestive Therapeutics, Inc. (AQST) | 16-Mar-20 | Market Purchase | 2,000 | $1.50 | $3,000.00 | 4% 50.24K to 52.24K | 335% |
13-Aug-19 4:30 PM View: | Aquestive Therapeutics, Inc. (AQST) | 12-Aug-19 | Market Purchase | 600 | $3.81 | $2,286.00 | 1% 49.64K to 50.24K | 71% |
26-Nov-18 1:35 PM View: | Aquestive Therapeutics, Inc. (AQST) | 21-Nov-18 | Purchase | 200 | $9.98 | $1,996.00 | < 1% 49.44K to 49.64K |